{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:53:03Z","timestamp":1787165583584,"version":"build-2736575974"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Polypharmacy is common in patients with dysphagia. Routinely used drugs may influence swallowing function either improving or worsening it. We aimed to explore the potential effects of three commonly used drug classes on dysphagia and aspiration pneumonia through a systematic review and a real-world data analysis to probe the possibility of drug repurposing for dysphagia treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Material and Methods:<\/jats:bold>\n                    Five electronic databases were searched. Studies on adults at risk for dysphagia, treated with Dipeptidyl-Peptidase IV Inhibitors (DPP-4i), Adrenergic Beta-Antagonists (beta-blockers), or Angiotensin-Converting Enzyme Inhibitors (ACEi), and reporting outcomes on dysphagia or aspiration pneumonia were included. A nested case\/non-case study was performed on adverse events recorded in the FDA Adverse Event Reporting System (FAERS) on patients &amp;gt;64\u00a0years. Cases (dysphagia or aspiration pneumonia) were compared between patients only treated with Levodopa and patients who were concomitantly treated with the drugs of interest.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Twenty studies were included in the review (17 on ACEi, 2 on beta-blockers, and 1 on DPP-4i). Contrasting findings on the effects of ACEi were found, with a protective effect mainly reported in Asian studies on neurological patients. Beta-blockers were associated with a reduced dysphagia rate. The study on DPP-4i suggested no effect on dysphagia and an increased risk of aspiration pneumonia. The FAERS analysis showed a reduction of the risk for dysphagia\/aspiration pneumonia with ACEi, beta-blockers, and DPP-4i.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Our study explores the potential drug repurposing of ACEi, beta-blockers and DPP-4i in neurological patients with dysphagia to improve swallowing function and reduce aspiration pneumonia risk. Future randomized controlled studies should confirm these results and clarify the underlying mechanisms of action.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2023.1057301","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T11:06:42Z","timestamp":1677841602000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Vera","family":"Battini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Guarnieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gringeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Carnovale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Pizzorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"B99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1196\/annals.1372.039","article-title":"Inflammatory process in type 2 diabetes: The role of cytokines","volume":"1084","author":"Alexandraki","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/01.WNL.0000150897.14961","article-title":"ACE inhibitors and protection against pneumonia in elderly patients with stroke","volume":"64","author":"Arai","year":"2005","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)85021-6","article-title":"ACE inhibitors and symptomless dysphagia","volume":"352","author":"Arai","year":"","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1378\/chest.119.2.660","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke","volume":"119","author":"Arai","year":"2001","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1378\/chest.117.6.1819","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia","volume":"117","author":"Arai","year":"2000","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0140-6736(05)60437-0","article-title":"ACE inhibitors and pneumonia in elderly people","volume":"352","author":"Arai","year":"","journal-title":"Lancet (London, Engl."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1212\/01.wnl.0000096395.80826.23","article-title":"Serum substance P concentrations and silent aspiration in elderly patients with stroke","volume":"61","author":"Arai","year":"2003","journal-title":"Neurology"},{"key":"B97","first-page":"A337","article-title":"The angiotensin converting enzyme regulates lipopolysaccharide-induced pulmonary neutrophil influx through bradykin and plasminogen activator inhibitor-1 pathways","volume":"3","author":"Arndt","year":"2006","journal-title":"Proc. Am. Thor, Society"},{"key":"B7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug. Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12913-018-3376-3","article-title":"Impact of oropharyngeal dysphagia on healthcare cost and length of stay in hospital: A systematic review","volume":"18","author":"Attrill","year":"2018","journal-title":"Bmc. Health. Serv. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/jnnp-2011-301590","article-title":"Ten-year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients","volume":"83","author":"Auyeung","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/CIA.S107750","article-title":"European society for swallowing disorders - European union geriatric medicine society white paper: Oropharyngeal dysphagia as a geriatric syndrome","volume":"11","author":"Baijens","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/000348940811701210","article-title":"Validity and reliability of the eating assessment tool (EAT-10)","volume":"117","author":"Belafsky","year":"2008","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1365-2222.1996.tb00534.x","article-title":"Beta-blocker induced asthma: A role for sensory nerve hyperresponsiveness?","volume":"26","author":"Belvisi","year":"1996","journal-title":"Clin. Exp. Allergy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ejim.2012.08.006","article-title":"Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality","volume":"23","author":"Bosch","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/brain\/awaa262","article-title":"Diabetes medications and risk of Parkinson's disease: A cohort study of patients with diabetes","volume":"143","author":"Brauer","year":"2020","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3163\/1536-5050.101.4.023","volume":"101","author":"Brown","year":"2013","journal-title":"Clin. JMLA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema","volume":"54","author":"Brown","year":"2009","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1378\/chest.14-1481","article-title":"Anatomy and neurophysiology of cough: CHEST guideline and expert panel report","volume":"146","author":"Canning","year":"2014","journal-title":"Chest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/14740338.2019.1668373","article-title":"Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: A pharmacovigilance-pharmacodynamic\/pharmacokinetic assessment through an analysis of the vigibase","volume":"18","author":"Carnovale","year":"","journal-title":"Expert. Opin. Drug. Saf."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00228-019-02691-4","article-title":"Interaction between paracetamol and lamotrigine: New insights from the FDA adverse event reporting system (FAERS) database","volume":"75","author":"Carnovale","year":"","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e14220","DOI":"10.1111\/nmo.14220","article-title":"Effects of pharmacological agents for neurogenic oropharyngeal dysphagia: A systematic review and meta-analysis","volume":"34","author":"Cheng","year":"2022","journal-title":"Neurogastroenterol. Motil."},{"key":"B22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.clnu.2008.06.011","article-title":"Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration","volume":"27","author":"Clav\u00e9","year":"2008","journal-title":"Clin. Nutr."},{"key":"B23","unstructured":"Clinical Pharmacology powered by elsevier ClinicalKey2020"},{"key":"B24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/s0167-4838(97)00134-9","article-title":"Proline specific peptidases","volume":"1343","author":"Cunningham","year":"1997","journal-title":"Biochim. Biophys. Acta."},{"key":"B25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-6632.2010.05826.x","article-title":"Neurokinin-1 receptor: Functional significance in the immune system in reference to selected infections and inflammation","volume":"1217","author":"Douglas","year":"2011","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1177\/0269881118795333","article-title":"Antipsychotic drug use and pneumonia: Systematic review and meta-analysis","volume":"32","author":"Dzahini","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.therap.2019.01.006","article-title":"Case-non-case studies: Principle, methods, bias and interpretation","volume":"74","author":"Faillie","year":"2019","journal-title":"Therapie"},{"key":"B28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jtxs.12573","article-title":"Relationship between polypharmacy, xerostomia, gustatory sensitivity, and swallowing complaints in the elderly: A multidisciplinary approach","volume":"52","author":"Fernandes","year":"2021","journal-title":"J. Texture. Stud."},{"key":"B29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/00124363-200418050-00001","article-title":"Medical dictionary for regulatory activities (MedDRA)","volume":"18","author":"Fescharek","year":"2004","journal-title":"Pharm. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1111\/bcp.15258","article-title":"Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis","volume":"88","author":"Ganesh","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1177\/02698811211034810","article-title":"\u03b2-Adrenoceptor antagonists and nightmares: A pharmacoepidemiological-pharmacodynamic study","volume":"35","author":"Garcia","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/bcp.14459","article-title":"Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19","volume":"87","author":"Gatti","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/SHK.0b013e3180310f3a","article-title":"Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats","volume":"28","author":"He","year":"2007","journal-title":"Shock"},{"key":"B34","doi-asserted-by":"publisher","first-page":"A839","DOI":"10.1097\/SHK.0b013e3180310f3a","article-title":"Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced acute lung injury","volume":"3","author":"He","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"RRN1293","DOI":"10.1371\/currents.RRN1293","article-title":"Aspiration pneumonia and death in Huntington\u2019s disease","volume":"4","author":"Heemskerk","year":"2012","journal-title":"PLoS. Curr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/archneur.1994.00540220099020","article-title":"Aspiration and relative risk of medical complications following stroke","volume":"51","author":"Holas","year":"1994","journal-title":"Arch. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"114239","DOI":"10.1016\/j.ejmech.2022.114239","article-title":"Drug repositioning: Progress and challenges in drug discovery for various diseases","volume":"234","author":"Hua","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/00016489.2010.516013","article-title":"Cough reflex induced by capsaicin inhalation in patients with dysphagia","volume":"131","author":"Imoto","year":"2011","journal-title":"Acta. Otolaryngol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/brain\/awab015","article-title":"Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease","volume":"144","author":"Jeong","year":"2021","journal-title":"Brain"},{"key":"B40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/ajrccm.149.1.7509247","article-title":"Capsaicin desensitization inhibits swallowing reflex in Guinea pigs","volume":"149","author":"Jin","year":"1994","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: A brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"B42","first-page":"286","article-title":"Sputum substance P concentration and peak cough experimental flow in patients with ALS after administration of enalapril","volume":"17","author":"Kano","year":"2016","journal-title":"Amyotroph. Lateral. Scler. Front. Degener."},{"key":"B43","article-title":"Old drugs, new life","author":"Kerber","year":"2003"},{"key":"B44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00455-014-9584-z","article-title":"Prevalence of oropharyngeal dysphagia in The Netherlands: A telephone survey","volume":"30","author":"Kertscher","year":"2015","journal-title":"Dysphagia"},{"key":"B45","doi-asserted-by":"publisher","first-page":"104444","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104444","article-title":"Association between angiotensin-converting enzyme inhibitors and post-stroke aspiration pneumonia","volume":"28","author":"Kumazawa","year":"2019","journal-title":"J. Stroke. Cerebrovasc. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4103\/1673-5374.332122","article-title":"Parkinson's disease and diabetes mellitus: Common mechanisms and treatment repurposing","volume":"17","author":"Labandeira","year":"2022","journal-title":"Neural. Regen. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/archneur.1988.00520320068017","article-title":"Conditions associated with Huntington\u2019s disease at death. A case-control study","volume":"45","author":"Lanska","year":"1988","journal-title":"Arch. Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jamda.2015.05.009","article-title":"Does low dose angiotensin converting enzyme inhibitor prevent pneumonia in older people with neurologic dysphagia-A randomized placebo-controlled trial","volume":"16","author":"Lee","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2680.1998.1830139.x","article-title":"Tachykinins in propranolol-augmented, hyperpnoea-induced bronchoconstriction in Taida guinea-pigs: effects of dimethylthiourea","volume":"18","author":"Lin","year":"1998","journal-title":"J. Auton. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/HJH.0b013e328357a87a","article-title":"Angiotensin-converting enzyme inhibitor\/angiotensin II receptor blockers and pneumonia risk among stroke patients","volume":"30","author":"Liu","year":"2012","journal-title":"J. Hypertens."},{"key":"B50","first-page":"17","article-title":"Jumpstart to products","volume":"222","author":"Longman","year":"2004","journal-title":"Vivo-New York Then Norwalk"},{"key":"B51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0167-0115(97)00029-3","article-title":"The effects of tachykinins on inflammatory and immune cells","volume":"70","author":"Maggi","year":"1997","journal-title":"Regul. Pept."},{"key":"B52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PHM.0b013e3181909b73","article-title":"Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: A case-control study","volume":"88","author":"Marciniak","year":"2009","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1111\/ene.14998","article-title":"Healthcare costs of post-stroke oropharyngeal dysphagia and its complications: Malnutrition and respiratory infections","volume":"28","author":"Marin","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B54","first-page":"605","article-title":"Beneficial effect of perindopril in post-stroke patients with dysphagia","volume":"27","author":"Matsumoto","year":"2012","journal-title":"Dysphagia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ijnp\/pyab005","article-title":"Hyponatremia following antipsychotic treatment: In silico pharmacodynamics analysis of spontaneous reports from the US Food and drug administration adverse event reporting system database and an updated systematic review","volume":"24","author":"Mazhar","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40263-019-00631-5","article-title":"Association of hyponatraemia and antidepressant drugs: A pharmacovigilance-pharmacodynamic assessment through an analysis of the US Food and drug administration adverse event reporting system (FAERS) database","volume":"33","author":"Mazhar","year":"2019","journal-title":"CNS Drugs"},{"key":"B96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.me.39.020188.000313","article-title":"Swallowing disorders","volume":"39","author":"Merlo","year":"1988","journal-title":"Annu. Rev. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00455-016-9735-5","article-title":"Drugs related to oropharyngeal dysphagia in older people","volume":"31","author":"Miarons","year":"2016","journal-title":"Dysphagia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e13397","DOI":"10.1111\/nmo.13397","article-title":"Increased levels of substance P in patients taking beta-blockers are linked with a protective effect on oropharyngeal dysphagia","volume":"30","author":"Miarons","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"B59","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1152\/jappl.1997.83.2.459","article-title":"Chronic beta-blockade increases skeletal muscle beta-adrenergic-receptor density and enhances contractile force","volume":"83","author":"Murphy","year":"1997","journal-title":"J. Appl. Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/s0140-6736(95)92638-0","article-title":"Sputum substance P in aspiration pneumonia","volume":"345","author":"Nakagawa","year":"1995","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MD.0b013e318224413b","article-title":"Nicergoline improves dysphagia by upregulating substance P in the elderly","volume":"90","author":"Nakashima","year":"2011","journal-title":"Med. Baltim."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1378\/chest.113.5.1425","article-title":"ACE inhibitor and swallowing reflex","volume":"113","author":"Nakayama","year":"1998","journal-title":"Chest"},{"key":"B63","unstructured":"2020"},{"key":"B64","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00455-017-9867-2","article-title":"Relationship between frequency of spontaneous swallowing and salivary substance P level in patients with acute stroke","volume":"33","author":"Niimi","year":"2018","journal-title":"Dysphagia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00228-019-02794-y","article-title":"Association between dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: Disproportionality analysis using the spontaneous reporting system in Japan","volume":"76","author":"Noguchi","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1164\/rccm.200309-1219OC","article-title":"Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk","volume":"169","author":"Ohkubo","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/s0895-7061(99)00035-7","article-title":"Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients","volume":"12","author":"Okaishi","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"B68","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B70","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1044\/2021_AJSLP-20-00375","article-title":"Risk of an adverse event in individuals who aspirate: A review of current literature on host defenses and individual differences","volume":"31","author":"Palmer","year":"2022","journal-title":"Am. J. Speech. Lang. Pathol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0003-9969(92)90076-k","article-title":"Methionine enkephalin-like, substance P-like, and \u03b2-endorphin-like immunoreactivity in human parotid saliva","volume":"37","author":"Pikula","year":"1992","journal-title":"Arch. Oral. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.102.037382","article-title":"Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome","volume":"303","author":"Raiden","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1196\/annals.1423.042","article-title":"Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses","volume":"1110","author":"Reinhold","year":"2007","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.2337\/dc05-2486","article-title":"Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy","volume":"29","author":"Restivo","year":"2006","journal-title":"Diabetes Care"},{"key":"B75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1254\/jphs.91.87","article-title":"Roles of substance P and NK(1) receptor in the brainstem in the development of emesis","volume":"91","author":"Saito","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jcpt.12011","article-title":"Effect of pilocarpine on substance P and calcitonin gene-related peptide releases correlate with salivary secretion in human saliva and plasma","volume":"38","author":"Sato","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fneur.2019.00386","article-title":"Substance P saliva reduction predicts pharyngeal dysphagia in Parkinson's disease","volume":"10","author":"Schr\u00f6der","year":"2019","journal-title":"Front. Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/pulp.1996.0042","article-title":"Role of substance P in cough","volume":"9","author":"Sekizawa","year":"1996","journal-title":"Pulm. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0140-6736(05)60114-6","article-title":"ACE inhibitors and pneumonia","volume":"352","author":"Sekizawa","year":"1998","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00415-006-0157-4","article-title":"ACE inhibitor and swallowing difficulties in stroke. A preliminary study","volume":"255","author":"Shimizu","year":"2008","journal-title":"J. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"B83","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B84","first-page":"23","article-title":"Rediscovering existing drugs","volume":"9","author":"Stuart","year":"2004","journal-title":"Start-Up"},{"key":"B85","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/s1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/mds.26734","article-title":"Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study","volume":"31","author":"Svenningsson","year":"2016","journal-title":"Mov. Disord."},{"key":"B87","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00455-016-9695-9","article-title":"A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson's disease, alzheimer's disease, head injury, and pneumonia","volume":"31","author":"Takizawa","year":"2016","journal-title":"Dysphagia"},{"key":"B88","unstructured":"Adverse event reporting system (FAERS)2020"},{"key":"B89","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00455-021-10248-w","article-title":"Oropharyngeal dysphagia in older people is associated with reduced pharyngeal sensitivity and low substance P and CGRP concentration in saliva","volume":"37","author":"Tomsen","year":"2022","journal-title":"Dysphagia"},{"key":"B90","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/HJH.0b013e328010520a","article-title":"Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes","volume":"25","author":"van de Garde","year":"2007","journal-title":"J. Hypertens."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00455-021-10387-0","article-title":"Six-year follow-up of dysphagia in patients with Parkinson's disease","volume":"37","author":"Wang","year":"2022","journal-title":"Dysphagia"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1212\/WNL.0000000000011350","article-title":"Neurogenic dysphagia: Systematic review and proposal of a classification system","volume":"96","author":"Warnecke","year":"2021","journal-title":"Neurology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2337\/dc10-1771","article-title":"Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: A disproportionality analysis in the world health organization VigiBase","volume":"34","author":"Willemen","year":"2011","journal-title":"Diabetes Care"},{"key":"B94","doi-asserted-by":"publisher","first-page":"21955","DOI":"10.1038\/s41598-021-99858-w","article-title":"Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs","volume":"11","author":"Wolf","year":"2021","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00441-018-2922-y","article-title":"Substance P and pain chronicity","volume":"375","author":"Zieglg\u00e4nsberger","year":"2019","journal-title":"Cell. Tissue. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1057301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T11:06:53Z","timestamp":1677841613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1057301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":99,"alternative-id":["10.3389\/fphar.2023.1057301"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1057301","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"article-number":"1057301"}}